Helicobacter pylori and immunotherapy for gastrointestinal cancer

Helicobacter pylori and immunotherapy for gastrointestinal cancer

Helicobacter pylori infection is associated with the risk of gastrointestinal (GI) cancers; however, its impact on immunotherapy for GI cancers remains uncertain. In this study, we included 10,122 patients who underwent 13C-urea breath tests. Among 636 patients with Epstein-Barr virus–negative micro...

Full description

Bibliographic Details
Main Authors: Keren Jia, Yang Chen, Yi Xie, Xicheng Wang, Yajie Hu, Yu Sun, Yanshuo Cao, Liyan Zhang, Yakun Wang, Zhenghang Wang, Zhihao Lu, Jian Li, Xiaotian Zhang, Lin Shen
Format: Article
Language:English
Published: Elsevier 2024-03-01
Series:The Innovation
Online Access:http://www.sciencedirect.com/science/article/pii/S2666675823001893

Internet

http://www.sciencedirect.com/science/article/pii/S2666675823001893

Similar Items